World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03495830
Date of registration: 21/03/2018
Prospective Registration: Yes
Primary sponsor: University of Belgrade
Public title: Stratification of Patient With Carotid Disease TAXINOMISIS
Scientific title: Observational Multicentre Clinical Trial for Validation of Taxinomisis, New Stratification Tool for Stroke Risk in Patients With Carotid Disease
Date of first enrolment: March 29, 2018
Target sample size: 270
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03495830
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Germany Netherlands Serbia Spain
Contacts
Name:     Themis Exarchos, PhD
Address: 
Telephone: 00306947709387
Email: themis.exarchos@gmail.com
Affiliation: 
Name:     Dimitris Fotiadis, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Ionania
Key inclusion & exclusion criteria

Inclusion Criteria:

- Extracranial carotid stenosis greater than 50% stenosis (NASCET) in the carotid
bifurcation or internal carotid artery assessed by means of ultrasound;

- Ability of the patient for follow-up examinations;

- Personally signed informed consent

Exclusion Criteria:

- Previous haemorrhagic stroke,

- Non-atherosclerotic carotid stenosis (e.g. dissection, floating thrombus,
fibromuscular dysplasia, postirradiation lesion)

- Presence of stenotic lesions in the proximal common carotid artery,

- Recurrent carotid stenosis after CEA or CAS,

- Carotid aneurysm

- Bilateral carotid occlusion,

- Severe aortic arch calcifications and shaggy aorta

- Intracranial angioma or aneurysms,

- Severe pre-existing disability (modified Rankin scale = 3);

- Contraindications for heparin, ASA and clopidogrel therapy

- Contraindication for MRI examination (metal implants, claustrophobia);

- Increased risk of thrombotic or embolic events (congenital or acquired thrombotic
conditions, active untreated cancer, atrial fibrillation, severe cardiomyopathy with
ejection fraction lower than 30%);

- Planned major surgery and/or life expectancy less than 3 years



Age minimum: 40 Years
Age maximum: 85 Years
Gender: All
Health Condition(s) or Problem(s) studied
Carotid Artery Stenosis
Intervention(s)
Procedure: Carotid endarterectomy
Primary Outcome(s)
Combined stroke, transitory ischemic attach and retinal transitory ischemic attach [Time Frame: 3 years]
Secondary Outcome(s)
Silent brain lesions [Time Frame: 3 years]
Secondary ID(s)
755320
STRATIFY
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Utrecht University
Ludwig-Maximilians - University of Munich
University of Athens
University of Barcelona
University of Genova
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history